Cellebrite DI (CLBT) Total Liabilities (2019 - 2025)

Cellebrite DI's Total Liabilities history runs 7 years deep, the most recent figure standing at $454.5 million for Q4 2025.

• In Q4 2025, Total Liabilities rose 28.2% year-over-year to $454.5 million; the TTM figure through Dec 2025 stood at $454.5 million (up 28.2% YoY), while the FY2025 annual figure was $454.5 million, up 28.2% from the prior year.
• Total Liabilities was $454.5 million for Q4 2025 at Cellebrite DI, up from $386.6 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $596.7 million in Q2 2024 to a low of $293.0 million in Q3 2022.
• Historically, Total Liabilities has averaged $402.4 million across 5 years, with a median of $382.8 million in 2025.
• The sharpest annual moves came in 2021 and 2025: Total Liabilities jumped 107.21% in 2021, then slumped 37.68% in 2025.
• A 5-year view of Total Liabilities shows it stood at $413.1 million in 2021, then declined by 20.26% to $329.4 million in 2022, then soared by 51.38% to $498.7 million in 2023, then decreased by 28.9% to $354.5 million in 2024, then increased by 28.2% to $454.5 million in 2025.
• The last three Total Liabilities figures came in at $454.5 million (Q4 2025), $386.6 million (Q3 2025), and $379.0 million (Q2 2025), per Business Quant data.